Dividend policy

The guiding principle of the Issuer’s Management Board regarding dividends is to pay dividends in accordance with the amount of profit generated and the current capabilities of the Issuer.

The Management Board submits proposals concerning dividend payment with consideration of the need to ensure the financial liquidity of the Issuer and secure the capital required for business development.

When deciding on the recommendation of dividend payment, the Management Board of the Issuer considers, in particular, the current and future financial situation of the Issuer’s Group, strategic objectives and the effectiveness of the investment projects planned by the Issuer’s Group.

Amount of dividend for every fiscal year from 2010 to 2017:

Item 2013 2014 2015 2016 2017 2018 2019
Consolidated net income (PLN thousand) 6,909

10,019

10,307

14,841

5,364

7,045

-2,031

Amount of planned divided (PLN thousand)

259

2,161

0

1,377

0

0

5,295

Amount of approved and paid-out dividend (PLN thousand)

259

2,161

0

1,377

0

0

5,203 *

Number of shares

8,643,400

8,643,400

8,643,400

10,589,100

10,589,100

10,589,100

10,603,414

Par value of a share (PLN)

1

1

1

1

1

1

1

Dividend value per share (PLN)

0.03

0.25

0.00

0.13

0.00

0.00

0.50

Dividend day

8.07.2014

2.07.2015

-

11.07.2017

-

-

19.06.2020

Payment date

25.07.2014

20.07.2015

-

18.07.2017

-

-

26.06.2020

 

* The dividend was not paid for own shares acquired by the Issuer

Fraud alert

Dear Ladies and Gentlemen,

We kindly inform you that the website https://mercatorgloves.com is not related to Mercator Medical Group and should be considered as a scam and unlawful impersonation of Mercator Medical S.A. or the Mercator Medical Group. We bear no responsibility for any unlawful activities or false information originating from the aforementioned website and other online and offline channels that falsely impersonate the Company. The Company’s only official website is https://mercatormedical.eu.

Mercator Medical Group will report any suspicious or unlawful activities undertaken by any person or organisation falsely impersonating the Company to the relevant authorities, and reserves the right to take legal action against fraudsters.

With reference to information we have received about attempts to impersonate Mercator Medical S.A. or Mercator Medical Group companies to fraudulently obtain an advance payment for allegedly owned merchandise, we urge you to exercise caution and carefully verify your business partners.

Mercator Medical Team

Close
Fraud alert